Meridian Bioscience (FRA:MR4) Price-to-Operating-Cash-Flow : 18.28 (As of Apr. 26, 2024)

View and export this data going back to 1986. Start your Free Trial

What is Meridian Bioscience Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Meridian Bioscience's share price is €30.90. Meridian Bioscience's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 was €1.69. Hence, Meridian Bioscience's Price-to-Operating-Cash-Flow Ratio for today is 18.28.

The historical rank and industry rank for Meridian Bioscience's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:MR4's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 19.22
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Meridian Bioscience's Cash Flow from Operations per share for the three months ended in Sep. 2022 was €0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 was €1.69.

Meridian Bioscience Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Meridian Bioscience's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience Price-to-Operating-Cash-Flow Chart

Meridian Bioscience Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

18.30

11.26

15.28

12.67

16.99

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															12.67	11.62	12.54	14.16	16.99

Competitive Comparison of Meridian Bioscience's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Meridian Bioscience's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meridian Bioscience's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's Price-to-Operating-Cash-Flow falls into.

Meridian Bioscience Price-to-Operating-Cash-Flow Calculation

Meridian Bioscience's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	30.90	/	1.69
	=	18.28

Meridian Bioscience's Share Price of today is €30.90.
Meridian Bioscience's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.69.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Meridian Bioscience Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (FRA:MR4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (FRA:MR4) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

3471 River Hills Drive, Cincinnati, OH, USA, 45244

Website

https://www.meridianbioscience.com

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Meridian Bioscience (FRA:MR4) Headlines

No Headlines